Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a smartphone app ease the stress of cancer genetic testing?

NCT ID NCT07387263

Recruiting now Knowledge-focused Sponsor: Unity Health Toronto Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a digital app called the Genetics Adviser for Mainstream Care (GA-Mainstream) that educates cancer patients about genetic testing and delivers their results. Researchers want to see if using the app reduces distress and improves the patient experience compared to standard care. The study will enroll 180 adults with breast, prostate, colon, ovarian, or pancreatic cancer who are already getting genetic testing through their oncologist.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Genetics Adviser for Mainstream Care (GA-Mainstream) digital application
What this could lead to
If successful, this could provide a standard, evidence-based digital tool to support cancer patients through genetic testing, reducing anxiety and improving coordination of care.
What could go wrong
This is a relatively small, early-stage study (180 participants) testing a behavioral intervention, not a drug. The app may not significantly reduce distress compared to standard care, and results may not apply to non-English speakers or those without internet access.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm cancer colon carcinoma colonic neoplasm digestive system cancer malignant pancreatic neoplasm neoplasm ovarian cancer pancreatic neoplasm prostate cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BREAST CANCER CANCER COLON CANCER GI CANCERS OVARIAN CANCER PANCREATIC CANCER PROSTATE CANCER

Contacts and locations

Locations

  • Mount Sinai Hospital

    RECRUITING

    Toronto, Ontario, M5G 1X5, Canada

  • Sunnybrook Hospital

    RECRUITING

    Toronto, Ontario, M4N 3M5, Canada

More trials for these conditions

Other studies related to the condition(s) this trial covers.